Cite
HARVARD Citation
Jeanson, A. et al. (2019). Therapeutic potential of trametinib to inhibit the mutagenesis by inactivating the protein kinase pathway in non-small cell lung cancer. Expert review of anticancer therapy. 19 (1), pp. 11-17. [Online].